United States - English - NLM (National Library of Medicine)

xellia pharmaceuticals usa llc - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection, usp is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (β-lactam-resistant) staphylococci. it is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. vancomycin hydrochloride for injection, usp is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly. vancomycin hydrochloride for injection, usp is effective in the treatment of staphylococcal endocarditis. its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin-structure infections. when staphylococcal infecti

United States - English - NLM (National Library of Medicine)

mylan institutional llc - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of septicemia due to: vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of infective endocarditis due to: vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of early-onset prosthetic valve endocarditis caused by staphylococcus epidermidis in combination with rifampin and an aminoglycoside. vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of skin and skin structure infections due to: vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of bone infections due to: vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of lower respira

United States - English - NLM (National Library of Medicine)

meitheal pharmaceuticals inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of septicemia due to: - susceptible isolates of methicillin-resistant staphylococcus aureus (mrsa) and coagulase negative staphylococci. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receive or who have failed to respond to other drugs, including penicillins or cephalosporins. vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of infective endocarditis due to: - susceptible isolates of mrsa. - viridans group streptococci streptococcus gallolyticus (previously known as streptococcus bovis ), enterococcus species and corynebacterium species. for enterococcal endocarditis, use vancomycin hydrochloride for injection in combination with an aminoglycoside. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receiv

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of septicemia due to: - susceptible isolates of methicillin-resistant staphylococcus aureus (mrsa) and coagulase negative staphylococci. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receive or who have failed to respond to other drugs, including penicillins or cephalosporins. vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of infective endocarditis due to: - susceptible isolates of mrsa. - viridans group streptococci streptococcus gallolyticus (previously known as streptococcus bovis ), enterococcus species and corynebacterium species. for enterococcal endocarditis, use vancomycin hydrochloride for injection in combination with an aminoglycoside. - methicillin-susceptible staphylococci in

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of septicemia due to: - susceptible isolates of methicillin-resistant staphylococcus aureus (mrsa) and coagulase negative staphylococci. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receive or who have failed to respond to other drugs, including penicillins or cephalosporins. vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of infective endocarditis due to: - susceptible isolates of mrsa. - viridans group streptococci streptococcus gallolyticus (previously known as streptococcus bovis ), enterococcus species and corynebacterium species. for enterococcal endocarditis, use vancomycin hydrochloride for injection in combination with an aminoglycoside. - methicillin-susceptible staphylococci in

United States - English - NLM (National Library of Medicine)

zhejiang novus pharma co., ltd. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of septicemia due to: - susceptible isolates of methicillin-resistant staphylococcus aureus (mrsa) and coagulase negative staphylococci. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receive or who have failed to respond to other drugs, including penicillins or cephalosporins. vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of infective endocarditis due to: - susceptible isolates of mrsa. - viridans group streptococci streptococcus gallolyticus (previously known as streptococcus bovis ), enterococcus species and corynebacterium species. for enterococcal endocarditis, use vancomycin hydrochloride for injection in combination with an aminoglycoside. - methicillin-susceptible staphylococci in

United States - English - NLM (National Library of Medicine)

zhejiang novus pharma co., ltd. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of septicemia due to: - susceptible isolates of methicillin-resistant staphylococcus aureus (mrsa) and coagulase negative staphylococci. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receive or who have failed to respond to other drugs, including penicillins or cephalosporins. vancomycin hydrochloride for injection administered intravenously is indicated in adults and pediatric patients less than 18 years of age for the treatment of infective endocarditis due to: - susceptible isolates of mrsa. - viridans group streptococci streptococcus gallolyticus (previously known as streptococcus bovis ), enterococcus species and corynebacterium species. for enterococcal endocarditis, use vancomycin hydrochloride for injection in combination with an aminoglycoside. - methicillin-susceptible staphylococci in

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of septicemia due to: - susceptible isolates of methicillin-resistant staphylococcus aureus (mrsa) and coagulase negative staphylococci. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receive or who have failed to respond to other drugs, including penicillins or cephalosporins. vancomycin hydrochloride for injection is indicated in adults and pediatric patients (neonates and older) for the treatment of infective endocarditis due to: - susceptible isolates of mrsa. - viridans group streptococci streptococcus gallolyticus (previously known as streptococcus bovis ), enterococcus species and corynebacterium species. for enterococcal endocarditis, use vancomycin hydrochloride for injection in combination with an aminoglycoside. - methicillin-susceptible staphylococci in penicillin-allergic patients, or those patients who cannot receiv

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - vancomycin hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - vancomycin hydrochloride -